University of California, Los Angeles
13 articles about University of California, Los Angeles
-
UCLA/Luskin Orthopaedic Institute for Children to Host Professional Conference and Family Forum for National Cerebral Palsy Awareness Day on March 25, 2023
3/22/2023
Cerebral palsy is the most common childhood physical disability in the United States and throughout the world.
-
CancerVax Universal Cancer Vaccine Being Developed by UCLA
3/17/2023
CancerVAX, Inc. announced that its sponsored research program with the University of California Los Angeles to research and develop a universal cancer vaccine is now fully under way.
-
Published UCLA and Spectrum Solutions Saliva Liquid Biopsy Research Highlights Signal Amplifying Ability and Clear Detection of Cancer Biomarkers
7/26/2022
Spectrum Solutions, LLC announced the publishing of findings from their research collaboration with the University of California at Los Angeles and Dr. David Wong, UCLA School of Dentistry.
-
UCLA researchers report gene therapy may correct a rare creatine deficiency disorder that results in intellectual disabilities, issues with speech, involuntary movements and recurrent seizures.
-
Researchers at the University of California, Los Angeles have identified a neurological mechanism behind memory linking.
-
Long COVID is loosely defined as COVID-19 symptoms that persist for longer than four weeks from an initial diagnosis. Here’s a look at the latest in long COVID research.
-
Octant announced an $80 million Series B financing round, a Deep Mutual Scanning (DMS) biopharma partnership with Bristol Myers Squibb and key appointments to its leadership.
-
Deepcell, a biotechnology company spun out of Stanford University in 2017, focuses on quantifying and understanding morphology – part of the cell’s phenotype.
-
Qulipta is the first calcitonin gene-related peptide (CGRP) receptor antagonist specifically developed for this indication.
-
CancerVAX Announces Research Program to Develop Its First Immunotherapy Cancer Treatment
5/26/2021
The Company has entered into an agreement with UCLA to develop an immunotherapy breakthrough targeted at treating Ewing sarcoma, a rare but deadly soft tissue and bone cancer that primarily affects children and young adults
-
Being Overweight May Be Linked to Better Survival from Stroke
3/4/2019
It may seem counterintuitive, but having some extra body fat may be linked to an increased chance of surviving a stroke, according to a preliminary study released that will be presented at the American Academy of Neurology's 71st Annual Meeting in Philadelphia, May 4 to 10, 2019.
-
Helperby Therapeutics and UCLA to Collaborate on New Fast Track Antibiotic Therapies Aiming to Bring New Sophisticated Combination Therapies to Market in a Much-Reduced Timescale
11/13/2018
WHO World Antibiotic Awareness week 2018 [12-18 November]
-
Merus Announces Formation of a Scientific Advisory Board
8/22/2018
Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced the formation of a Scientific Advisory Board (SAB), consisting of several world-renowned immuno-oncology and drug development professionals.